Generic Name
Dicyclomine
FDA approval date: September 30, 1974
Classification: Anticholinergic
Form: Injection, Tablet, Capsule, Solution
What is Dicyclomine?
Dicyclomine hydrochloride is indicated for the treatment of patients with functional bowel/irritable bowel syndrome. Dicyclomine is an antispasmodic and anticholinergic agent indicated for the treatment of functional bowel/irritable bowel syndrome
Approved To Treat
Save this treatment for later
Not sure about your diagnosis?
Related Clinical Trials
There is no clinical trials being done for this treatment